UnitedHealth Group (NYSE:UNH – Get Rating) had its price objective increased by investment analysts at SVB Leerink from $550.00 to $600.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. SVB Leerink’s price objective indicates a potential upside of 12.34% from the […]